These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15315924)

  • 1. Adding rivastigmine to antipsychotics in the treatment of a chronic delirium.
    Dautzenberg PL; Mulder LJ; Olde Rikkert MG; Wouters CJ; Loonen AJ
    Age Ageing; 2004 Sep; 33(5):516-7. PubMed ID: 15315924
    [No Abstract]   [Full Text] [Related]  

  • 2. [Successful treatment of three elderly patients suffering from prolonged delirium using the cholinesterase inhibitor rivastigmine].
    Kalisvaart CJ; Boelaarts L; de Jonghe JF; Hovinga IM; Kat MG
    Ned Tijdschr Geneeskd; 2004 Jul; 148(30):1501-4. PubMed ID: 15481575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial.
    van Eijk MM; Roes KC; Honing ML; Kuiper MA; Karakus A; van der Jagt M; Spronk PE; van Gool WA; van der Mast RC; Kesecioglu J; Slooter AJ
    Lancet; 2010 Nov; 376(9755):1829-37. PubMed ID: 21056464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delirium in elderly hospitalised patients: protective effects of chronic rivastigmine usage.
    Dautzenberg PL; Mulder LJ; Olde Rikkert MG; Wouters CJ; Loonen AJ
    Int J Geriatr Psychiatry; 2004 Jul; 19(7):641-4. PubMed ID: 15254920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rivastigmine treatment as an add-on to antipsychotics in patients with schizophrenia and cognitive deficits.
    Chouinard S; Stip E; Poulin J; Melun JP; Godbout R; Guillem F; Cohen H
    Curr Med Res Opin; 2007 Mar; 23(3):575-83. PubMed ID: 17355738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholinesterase inhibitor initiation in hospital setting.
    Wagle KC; Taffet GE; Natali B
    J Am Geriatr Soc; 2011 Oct; 59(10):1988-9. PubMed ID: 22091527
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute dystonic reaction with rivastigmine.
    Dhikav V; Anand KS
    Int Psychogeriatr; 2013 Aug; 25(8):1385-6. PubMed ID: 23561545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot study of rivastigmine in the treatment of delirium after stroke: a safe alternative.
    Oldenbeuving AW; de Kort PL; Jansen BP; Kappelle LJ; Roks G
    BMC Neurol; 2008 Sep; 8():34. PubMed ID: 18803862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Successful treatment of three elderly patients suffering from prolonged delirium using the cholinesterase inhibitor rivastigmine].
    van den Bliek BM; Maas HA
    Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2149; author reply 2149. PubMed ID: 15553363
    [No Abstract]   [Full Text] [Related]  

  • 10. Delirium treatment: an unmet challenge.
    Skrobik Y
    Lancet; 2010 Nov; 376(9755):1805-7. PubMed ID: 21056463
    [No Abstract]   [Full Text] [Related]  

  • 11. A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease--rivastigmine patch versus capsule.
    Winblad B; Cummings J; Andreasen N; Grossberg G; Onofrj M; Sadowsky C; Zechner S; Nagel J; Lane R
    Int J Geriatr Psychiatry; 2007 May; 22(5):456-67. PubMed ID: 17380489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IDEAL: a 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease.
    Winblad B; Grossberg G; Frölich L; Farlow M; Zechner S; Nagel J; Lane R
    Neurology; 2007 Jul; 69(4 Suppl 1):S14-22. PubMed ID: 17646619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Delirium in the elderly].
    Singler K; Singler B; Heppner HJ
    Dtsch Med Wochenschr; 2011 Apr; 136(14):681-4. PubMed ID: 21448826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of rivastigmine for delirium in intensive care is stopped after deaths.
    Sheldon T
    BMJ; 2010 May; 340():c2895. PubMed ID: 20511318
    [No Abstract]   [Full Text] [Related]  

  • 15. [Transdermal rivastigmine patch in outpatient services in Austria: a naturalistic study in 103 patients with Alzheimer dementia].
    Schmidt R; Alf C; Bancher C; Benke T; Berek K; Dal-Bianco P; Führwürth G; Imarhiagbe D; Jagsch C; Lechner A; Rainer M; Reisecker F; Rotaru J; Uranüs M; Walter A; Winkler A; Wuschitz A
    Neuropsychiatr; 2009; 23(1):58-63. PubMed ID: 19272293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of cholinesterase-inhibitor use in the nursing home setting: a retrospective analysis.
    Dybicz SB; Keohane DJ; Erwin WG; McRae T; Shah SN
    Am J Geriatr Pharmacother; 2006 Jun; 4(2):154-60. PubMed ID: 16860262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rivastigmine patch for dementia.
    Med Lett Drugs Ther; 2008 Mar; 50(1282):21-2. PubMed ID: 18356801
    [No Abstract]   [Full Text] [Related]  

  • 18. Rivastigmine dermal patch solves eating problems in an individual with advanced Alzheimer's disease.
    Uwano C; Suzuki M; Aikawa T; Ebihara T; Une K; Tomita N; Kosaka Y; Okinaga S; Furukawa K; Arai H; Ohrui T
    J Am Geriatr Soc; 2012 Oct; 60(10):1979-80. PubMed ID: 23057453
    [No Abstract]   [Full Text] [Related]  

  • 19. Rivastigmine treatment of Othello syndrome and post-ECT delirium in a patient with Parkinson's disease.
    Scicutella A
    J Neuropsychiatry Clin Neurosci; 2015; 27(1):e90. PubMed ID: 25716514
    [No Abstract]   [Full Text] [Related]  

  • 20. Cholinesterase inhibition as a possible therapy for delirium in vascular dementia: a controlled, open 24-month study of 246 patients.
    Moretti R; Torre P; Antonello RM; Cattaruzza T; Cazzato G
    Am J Alzheimers Dis Other Demen; 2004; 19(6):333-9. PubMed ID: 15633941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.